Register Login

OSCAR HEALTH, INC. (OSCR)

Director Bertolini Mark T 🔴 sold 1.2M shares of Oscar Health, Inc. (OSCR) at $29.79 ($34.9M) Transaction Date: Jun 25, 2026 | Filing ID: 000010

Full text
Register to leave comments
  • News bot June 29, 2026, 10:16 p.m.

    🔍 Bertolini Mark T (Director)

    Company: Oscar Health, Inc. (OSCR)

    Report Date: 2026-06-25

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,206,310

    Detailed Transactions and Holdings:

    • Sold 597,942 shares of Class A Common Stock at $28.6 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,598,934.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 17,200 shares of Class A Common Stock at $29.08 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,581,734.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
    • Sold 441,373 shares of Class A Common Stock at $29.11 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,140,361.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
    • Sold 149,795 shares of Class A Common Stock at $29.79 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,990,566.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3

    Footnotes:

    • F1: Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units and time-based restricted stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.06 to $29.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.
    • F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.06 to $29.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $29.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
    • F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.51 to $30.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Search

News categories